These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 6983827

  • 1. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
    Zanker B, Rasokat H, Hadding U, Bitter-Suermann D.
    Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
    [Abstract] [Full Text] [Related]

  • 2. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
    Meuer S, Ecker U, Hadding U, Bitter-Suermann D.
    J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973
    [Abstract] [Full Text] [Related]

  • 3. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y, Hugli TE.
    J Immunol; 1988 May 15; 140(10):3496-501. PubMed ID: 3283237
    [Abstract] [Full Text] [Related]

  • 4. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S, Hugli TE, Andreatta RH, Hadding U, Bitter-Suermann D.
    Inflammation; 1981 Dec 15; 5(4):263-73. PubMed ID: 6976935
    [Abstract] [Full Text] [Related]

  • 5. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.
    Hartung HP, Bitter-Suermann D, Hadding U.
    J Immunol; 1983 Mar 15; 130(3):1345-9. PubMed ID: 6600482
    [Abstract] [Full Text] [Related]

  • 6. Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.
    Meuer S, Zanker B, Hadding U, Bitter-Suermann D.
    J Exp Med; 1982 Mar 01; 155(3):698-710. PubMed ID: 6977607
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug 01; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 8. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
    Grossklaus C, Damerau B, Lemgo E, Vogt W.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct 01; 295(1):71-6. PubMed ID: 1004644
    [Abstract] [Full Text] [Related]

  • 9. Synthetic C3a analogs as specific inhibitors of C3a activity.
    Meuer S, Hadding U, Andreatta R, Bitter-Suermann D.
    Immunopharmacology; 1981 Sep 01; 3(3):275-80. PubMed ID: 6975766
    [Abstract] [Full Text] [Related]

  • 10. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.
    Becker S, Hadding U, Schorlemmer HU, Bitter-Suermann D.
    Scand J Immunol; 1978 Sep 01; 8(6):551-5. PubMed ID: 734357
    [Abstract] [Full Text] [Related]

  • 11. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
    Hoffmann T, Böttger EC, Baum HP, Messner M, Hadding U, Bitter-Suermann D.
    Clin Exp Immunol; 1988 Mar 01; 71(3):486-92. PubMed ID: 3260158
    [Abstract] [Full Text] [Related]

  • 12. Human platelet activation by C3a and C3a des-arg.
    Polley MJ, Nachman RL.
    J Exp Med; 1983 Aug 01; 158(2):603-15. PubMed ID: 6604123
    [Abstract] [Full Text] [Related]

  • 13. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
    del Balzo U, Polley MJ, Levi R.
    J Pharmacol Exp Ther; 1988 Sep 01; 246(3):911-6. PubMed ID: 2458450
    [Abstract] [Full Text] [Related]

  • 14. Reevaluation of the C3a active site using short synthetic C3a analogues.
    Köhl J, Casaretto M, Gier M, Karwath G, Gietz C, Bautsch W, Saunders D, Bitter-Suermann D.
    Eur J Immunol; 1990 Jul 01; 20(7):1463-8. PubMed ID: 2387312
    [Abstract] [Full Text] [Related]

  • 15. Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin.
    Becker S, Meuer S, Hadding U, Bitter-Suermann D.
    Scand J Immunol; 1978 Jul 01; 7(2):173-80. PubMed ID: 653315
    [Abstract] [Full Text] [Related]

  • 16. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
    Meuer S, Becker S, Hadding U, Bitter-Suermann D.
    Z Immunitatsforsch Immunobiol; 1978 Mar 01; 154(2):135-46. PubMed ID: 77089
    [Abstract] [Full Text] [Related]

  • 17. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W, Kretzschmar T, Stühmer T, Kola A, Emde M, Köhl J, Klos A, Bitter-Suermann D.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [Abstract] [Full Text] [Related]

  • 18. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL, Ember JA, Herdman DS, DiScipio RG, Hugli TE, Gigli I.
    J Immunol; 1995 Jul 01; 155(1):266-74. PubMed ID: 7602103
    [Abstract] [Full Text] [Related]

  • 19. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
    Burger R, Bader A, Kirschfink M, Rother U, Schrod L, Wörner I, Zilow G.
    Clin Exp Immunol; 1987 Jun 01; 68(3):703-11. PubMed ID: 3498585
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the C5a receptor on guinea pig platelets.
    Kretzschmar T, Kahl K, Rech K, Bautsch W, Köhl J, Bitter-Suermann D.
    Immunobiology; 1991 Nov 01; 183(5):418-32. PubMed ID: 1786990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.